AstraZeneca ' s Farxiga Fails to Get U.S. Approval for Type-1 Diabetes AstraZeneca ' s Farxiga Fails to Get U.S. Approval for Type-1 Diabetes

British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with a rare-type of the condition.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news